Original Query: ALL
Previous Study | Return to List | Next Study

Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00275054
Recruitment Status : Completed
First Posted : January 11, 2006
Last Update Posted : October 3, 2016
Information provided by:
German CLL Study Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2007
  Study Completion Date : June 2015